O
Omeros Corporation
OMER · NASDAQ · Healthcare · 1.2B
Closing price
$19.83
+3.71% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-812.7×
Free cash flow yieldFCF yield
-9.2%
Return on equityROE
2.8%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
-125.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.